Finally, peripheral blood mononuclear cells (PBMCs) extracted from MS patients demonstrated a hypersensitivity to TLR4 stimulation, being capable of activating a pro-inflammatory response [151]. This evidence concerns the gene TLR4 and myeloid sarcoma.